Gains in the current understanding of managing neovascular AMD with brolucizumab
ConclusionProgress has been made in understanding how to mitigate IOI-related adverse events following treatment with brolucizumab.
Source: Journal of Ophthalmic Inflammation and Infection - Category: Opthalmology Source Type: research